CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts

[1]  J. Delaunay,et al.  Contribution of GM-CSF and IL-8 to the CD44-induced differentiation of acute monoblastic leukemia , 2008, Leukemia.

[2]  O. Fadare,et al.  Clinical and pathologic aspects of basal-like breast cancers , 2008, Nature Clinical Practice Oncology.

[3]  S. Jothy,et al.  Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy. , 2007, Experimental and molecular pathology.

[4]  Aleksandra M. Michalowska,et al.  Transforming Growth Factor-β Can Suppress Tumorigenesis through Effects on the Putative Cancer Stem or Early Progenitor Cell and Committed Progeny in a Breast Cancer Xenograft Model , 2007 .

[5]  C. Hudis.  Trastuzumab--mechanism of action and use in clinical practice. , 2007, The New England journal of medicine.

[6]  A. Vincent-Salomon,et al.  A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays , 2007, Clinical Cancer Research.

[7]  J. Heath,et al.  Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel. , 2006, Cancer research.

[8]  M. Götte,et al.  Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. , 2006, Cancer research.

[9]  J. Dick,et al.  Targeting of CD44 eradicates human acute myeloid leukemic stem cells , 2006, Nature Medicine.

[10]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Roman Rouzier,et al.  Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.

[12]  J. Delaunay,et al.  The Effect of Anti-CD44 Monoclonal Antibodies on Differentiation and Proliferation of Human Acute Myeloid Leukemia Cells , 2004, Leukemia & lymphoma.

[13]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Dantzer,et al.  Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. , 2002, Cancer research.

[15]  A. O'Rourke,et al.  Tissue- and epitope-specific mechanisms account for the diverse effects of anti-CD44 antibodies on the maintenance of primitive hematopoietic progenitors in vitro. , 2000, Blood cells, molecules & diseases.

[16]  C. Riccardi,et al.  Cytostatic and cytotoxic effects of tumor necrosis factor alpha on MCF-7 human breast tumor cells are differently inhibited by glucocorticoid hormones. , 1993, Lymphokine and cytokine research.

[17]  Aleksandra M. Michalowska,et al.  Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. , 2007, Cancer research.

[18]  P. Herrlich,et al.  CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.

[19]  A. Balmain,et al.  TGF-beta signaling in tumor suppression and cancer progression. , 2001, Nature genetics.

[20]  L. Picker,et al.  Physiological and molecular mechanisms of lymphocyte homing. , 1992, Annual review of immunology.